JAN 23, 2019 01:54 PM PST

Stroke Drug May Prevent Alzheimer

WRITTEN BY: Nouran Amin

According to a study published in the Journal of Experimental Medicine, scientists at the University of Southern California discovered that a drug used for the treatment of stroke may also prevent Alzheimer's disease. The study shows that the brains of Alzheimer-model mice were protected from Alzheimer-like symptoms by a genetically modified version of a human blood protein (activated protein C) called ‘3K3A-APC’. The drug specifically protected the brain by reducing the buildup of toxic amyloid-beta peptides, preventing memory loss, and reducing inflammation—all common features of Alzheimer disease.

Learn more about Alzheimer disease:

3K3A-APC also reduces inflammation and protects both neurons and the cells that line the walls of blood vessels. Besides treating stroke--the protein was also shown to have positive effects on other models of disease including traumatic brain injury (TBI) and multiple sclerosis, and was clinically proven to be safe well-tolerated and capable of reducing intracerebral bleeding. "Because of its neuroprotective, vasculoprotective, and anti-inflammatory activities in multiple models of neurological disorders, we investigated whether 3K3A-APC can also protect the brain from the toxic effects of amyloid-beta toxin in a mouse model of Alzheimer's disease," says Berislav V. Zlokovic, the Director of the Zilkha Neurogenetic Institute at the Keck School of Medicine, University of Southern California.

3K3A-APC (right) greatly reduced the amount of amyloid-beta (green) that accumulated in brains of model mice that develop Alzheimer like symptoms in comparison with no treatment (left).

Credit: Lazic et al., 2019 via Science Daily

In the paper, 3K3A-APC protected the brain by preventing nerve cells from synthesizing an enzyme called BACE1 that in return produces amyloid-beta. Although several different inhibitors of BACE1 have gone through clinical trials, using 3K3A-APC for the inhibition of BACE1 is an alternative approach especially at early stages of the Alzheimer when amyloid-beta has not yet to accumulated to dangerous levels resulting in permanent damage in the brain. "Our present data support the idea that 3K3A-APC holds potential as an effective anti-amyloid-beta therapy for early stage Alzheimer's disease in humans," Zlokovic says.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Treating Drug-Resistant Acute Lymphoblastic Leukemia
New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing t...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Novel Therapy Shows Promise for Acute Migraines
In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Drug Reduces Heart Attacks in Diabetic Patients
Recent results from a clinical trial that evaluated the addition of a drug called ‘ticagrelor’ to aspirin were shown to improve clinical outcom...
OCT 22, 2019
Cannabis Sciences
OCT 22, 2019
CBD Alleviates Angelman Syndrome Seizures in Mice Trial
CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurolo...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Common Drug May Prevent Thousands Deaths from Head Injury
Each year, there are over 60 million new cases of traumatic brain injury (TBI). Mostly caused by road traffic crashes and falls, TBI often causes intracran...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Common Therapeutic Can Treat Bleeding Associated with Traumatic Brain Injury
An inexpensive and accessible drug was found to reduce rates of mortality associated with traumatic brain injury (TBI) patients by 20%. TBI is a major caus...
Loading Comments...